Thursday - April 9, 2026
New FDA Plausible Mechanism Framework Spurs Development of Personalized In Vivo Prime Editing Platform for Urea Cycle Disorders
March 31, 2026
PHILADELPHIA, Pennsylvania, March 31 [Category: BizHospital] -- Children's Hospital of Philadelphia issued the following news release:

* * *

New FDA Plausible Mechanism Framework Spurs Development of Personalized In Vivo Prime Editing Platform for Urea Cycle Disorders

*

Researchers from Children's Hospital of Philadelphia (CHOP) and Penn Medicine, along with collaborating institutions, reported results today supporting a customizable . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products